PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 14293906

[SYMPTOMATIC POLYGLOBULIA WITH SPECIAL REFERENCE TO RENAL POLYGLOBULIA].

A H FALKENHAHN·R PHLIPPEN
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Epoetin AlfaErythropoietinHumansKidneyKidney Diseases, CysticPolycythemia VeraUrographyERYTHROPOIETINKIDNEY, CYSTICPOLYCYTHEMIA VERAUROGRAPHYJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A H FALKENHAHN, R PHLIPPEN. 1965-04-24. [SYMPTOMATIC POLYGLOBULIA WITH SPECIAL REFERENCE TO RENAL POLYGLOBULIA].. https://pubmed.ncbi.nlm.nih.gov/14293906/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Advances in erythropoietic growth factor therapy for myelodysplastic syndromes.

Refractory anaemia associated with excessive intramedullary erythroid apoptosis and dysplasia is a major feature of myelodysplastic syndromes (MDS). Recombinant human erythropoietin (specifically, epoetin alfa [EPO]) has been used in the therapy of MDS for many years. Initially, the erythroid response rates were modest, as EPO was used in all subgroups of MDS patients without discretion. However, with increased sophistication in patient selection and response evaluation criteria, there has been a significant improvement in the response rates to EPO therapy. This review discusses the evolution of therapeutic strategies incorporating EPO for the treatment of MDS.

Epoetin Alfa↗